Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Lupus érythémateux disséminé () »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Lupus érythémateux disséminé < Lupus érythémateux disséminé () < Lupus érythémateux disséminé (anatomopathologie)  Facettes :

List of bibliographic references indexed by Lupus érythémateux disséminé ()

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
001673 (2017) Atsuko Iwai [Japon] ; Taio Naniwa [Japon] ; Shinya Tamechika [Japon] ; Shinji Maeda [Japon]Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis.
001A29 (2016) Vanessa Ocampo [Canada] ; Derek Haaland [Canada] ; K. Legault [Canada] ; Shika Mittoo [Canada] ; Emily Aitken [Canada]Successful treatment of recurrent pleural and pericardial effusions with tocilizumab in a patient with systemic lupus erythematous.
001C09 (2016) Jasmine N. Stannard [États-Unis] ; J Michelle KahlenbergCutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
002282 (2014) K. Takase [Royaume-Uni] ; S C Horton [Royaume-Uni] ; A. Ganesha [Royaume-Uni] ; S. Das [Royaume-Uni] ; A. Mchugh [Royaume-Uni] ; P. Emery [Royaume-Uni] ; S. Savic [Royaume-Uni] ; M H Buch [Royaume-Uni]What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.
003424 (2012) Francisco J. García-Hernández ; Rocío González-Le N ; María J. Castillo-Palma ; Celia Oca A-Medina ; Julio Sánchez-RománTocilizumab for treating refractory haemolytic anaemia in a patient with systemic lupus erythematosus.
003450 (2012) Ashima Makol [États-Unis] ; Lawrence E. Gibson ; Clement J. MichetSuccessful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis.
003454 (2012) K. Maeshima [Japon] ; K. Ishii ; M. Torigoe ; C. Imada ; M. Iwakura ; H. Hamasaki ; M. Akamine ; M. Haranaka ; H. YoshimatsuSuccessful tocilizumab and tacrolimus treatment in a patient with rheumatoid arthritis complicated by systemic lupus erythematosus.
003557 (2012) Yasuyuki Kamata [Japon] ; Seiji Minota [Japon]Successful treatment of massive intractable pericardial effusion in a patient with systemic lupus erythematosus with tocilizumab
003877 (2011) Miho Murakami [Japon] ; Norihiro NishimotoThe value of blocking IL-6 outside of rheumatoid arthritis: current perspective.
003A72 (2011) Kjell Tullus [Royaume-Uni]New developments in the treatment of systemic lupus erythematosus
003C71 (2010) Aisha Lateef [États-Unis] ; Michelle PetriBiologics in the treatment of systemic lupus erythematosus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Lupus érythémateux disséminé ()" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Lupus érythémateux disséminé ()" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Lupus érythémateux disséminé ()
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021